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Abstract
Background: Intracellular pathogens have developed elaborate strategies for silent infection of preferred host cells.
Chlamydia pneumoniae is a common pathogen in acute infections of the respiratory tract (e.g. pneumonia) and associated
with chronic lung sequelae in adults and children. Within the lung, alveolar macrophages and polymorph nuclear
neutrophils (PMN) are the first line of defense against bacteria, but also preferred host phagocytes of chlamydiae.
Methodology/Principal Findings: We could show that C. pneumoniae easily infect and hide inside neutrophil granulocytes
until these cells become apoptotic and are subsequently taken up by macrophages. C. pneumoniae infection of
macrophages via apoptotic PMN results in enhanced replicative activity of chlamydiae when compared to direct infection of
macrophages, which results in persistence of the pathogen. Inhibition of the apoptotic recognition of C. pneumoniae
infected PMN using PS- masking Annexin A5 significantly lowered the transmission of chlamydial infection to macrophages.
Transfer of apoptotic C. pneumoniae infected PMN to macrophages resulted in an increased TGF-ß production, whereas
direct infection of macrophages with chlamydiae was characterized by an enhanced TNF-a response.
Conclusions/Significance: Taken together, our data suggest that C. pneumoniae uses neutrophil granulocytes to be silently
taken up by long-lived macrophages, which allows for efficient propagation and immune protection within the human host.
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Introduction
Chlamydia pneumoniae is an obligate intracellular pathogen that
enters the human body after respiratory infection. Infection
activates airway epithelial cells resulting in a rapid recruitment of
polymorph nuclear neutrophil granulocytes (PMN) [1,2]. Conse-
quently, in the lung, PMN are among the first leukocytes to
encounter C. pneumoniae [3]. Importantly, phagocytosed C.
pneumoniae are not killed; the ingested bacteria survive and multiply
within PMN [4]. During the later course of the infection, viable
chlamydiae are found inside alveolar macrophages (AM),
bronchial/alveolar epithelial cells, vascular endothelial/smooth
muscle cells and monocyte- derived macrophages (MF) [4–8].
Chlamydiae undergo a biphasic developmental cycle inside an
internalized vesicle termed inclusion. Non dividing elementary
bodies (EBs) change into the dividing and metabolically active
reticulate bodies (RBs), re-differentiate to EBs and finally escape
from the host cell [9]. Productive infection and chlamydial
growth can be analyzed by inclusion morphology and size, but
also by monitoring transcriptional activity of chlamydial genes
involved in pathogen metabolism and pathogenicity throughout
the developmental cycle [10–12]. Increased production of the
pro-inflammatory cytokines IL-1ß and TNF-a have been
demonstrated as markers of direct host immune responses to
chlamydial infections in phagocytes [13,14], which may result in
intracellular killing of the bacteria.
One possible strategy to implement a productive infection is to
silently infect respective host cells. It has been suggested that
chlamydiae can benefit from a silent uptake resulting in increased
survival and growth [15]. The most extensively studied example of
a silent uptake into phagocytes is the clearance of apoptotic cells
which is a well organized three step process [16]. First, apoptotic
cells release ‘‘find-me’’ signals to recruit phagocytes to the site of
apoptotic death [17]. Second, phagocytes recognize the presence
of phosphatidylserine (PS) termed as ‘‘eat-me’’ signal on the
membrane of apoptotic cells [16]. The final step is an active
suppression of inflammation and immune response and can be
termed as a ‘‘forget me’’ signal. This step is characterized by the
release of anti-inflammatory cytokine TGF-ß and down-regulation
of the pro-inflammatory cytokine TNF-a.
In this study we could show, that C. pneumoniae make use of these
silent entry mechanisms to be taken up by monocyte- derived
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C. pneumoniae efficiently infect and replicate inside PMN, which
upon activation recruit monocytic phagocytes. C. pneumoniae
infected PMN then become apoptotic as shown by PS and
TUNEL positivity and are ingested by MF and AM, which secrete
increased amounts of anti-inflammatory TGF-ß.
Results
C. pneumoniae remains transcriptionally active inside
PMN
To determine whether C. pneumoniae survives the uptake by
PMN and remains viable intracellularly, we compared the
infection with productive C. pneumoniae infection in HEp-2 cells.
Using FACS we could show that 79%62% (n=3) of the HEp-2
cells and 83%67% (n=3) of the PMN stained C. pneumoniae- LPS
positive 66 h p.i. (MOI 1), whereas non-infected cells alone stained
negative (Fig. 1A,B). Microscopically, we observed that intracel-
lular C. pneumoniae inclusions in PMN were morphologically
different, showing multiple, smaller inclusions than in HEp-2 cells
(Fig. 1C,D).
To prove intracellular viability of chlamydiae inside PMN we
analyzed the transcriptional activity of chlamydial genes involved
in pathogen replication and metabolism. Expression of the 16S
rRNA of C. pneumoniae significantly increased from 3 h p.i. to 66 h
p.i. when compared to the 18S rRNA expression of the host cells,
indicating replication of chlamydiae inside PMN (Fig. 1E,
p=0.02). As a control, co- incubation of PMN with heat-killed
(HK) chlamydiae did not result in detectable amounts of 16S
rRNA (Fig. 1E). Key factors that indicate intracellular activity of
chlamydiae like the RNA polymerase (rpo) and the pyruvate
kinase (pyk) significantly increased within 66 h after PMN
infection (Fig. 1F, p=0.01 and p=0.03, respectively).
C. pneumoniae hides inside phosphatidylserine (PS)-
positive apoptotic PMN
PMN are short living cells. Even though C. pneumoniae infection
delays apoptosis of PMN, 48%68% of infected PMN become
apoptotic 66 h p.i. [4]. Using Annexin A5 (AnxA5) staining to
detect phosphatidylserine (PS) as an early marker of apoptosis on
the outer cell membrane, we could detect that both non- infected
(.95%, n=3) and C. pneumoniae- infected (82%612%, n=3)
PMN become PS- positive within 66 h (Fig. 2A,B). Additional
staining with PI showed that C. pneumoniae infection does not
increase the amount of necrotic cells compared to non- infected
PMNs (Fig. 2A,B). To visualize whether C. pneumoniae- infected
PMN stain positive for PS we performed a double staining using a
FITC- labeled anti-C. pneumoniae LPS and Alexa568-labeled
AnxA5 mAb (Fig. 2C). Within 66 h p.i. we observed that
86%66% (n=3) of C. pneumoniae- positive cells were expressing
PS on the cell surface (Fig. 2C).
To analyze late apoptotic PMNs we further performed the
TUNEL assay which reveals the apoptotic fragmentation of
nuclear DNA. Whereas only 62%63% (n=3) of the C. pneumoniae-
infected PMN became TUNEL- positive, more than 80% stained
positive in the non- infected control 66 h p.i. (Fig. 2D,E).
C. pneumoniae infected PMN release MIP-1ß, recruit and
enter macrophages
Macrophages (MF) represent the first line of defense in the lung
and are supposed to clear the lung from bacterial pathogens as
Figure 1. C. pneumoniae survives inside PMN. C. pneumoniae (Cp) infected HEp-2 cells and neutrophils (PMN) were analyzed 66 h p.i. for
intracellular positivity of chlamydial LPS by FACS analysis (A, B; representative experiment out of 3) and fluorescence microscopy (C, D; magnification
6306). To analyze intracellular progeny of C. pneumoniae in PMN we performed real-time RT-PCRs of the 16S rRNA in comparison to host cell 18S
rRNA using the DDct- method for relative quantification. Viable (open bars) but not heat-killed (HK, closed bars) chlamydiae showed a significant
increase in 16S rRNA expression (E) within 66 h p.i. (p=0.02; n=3). Enhanced transcriptional activity of C. pneumoniae inside PMN was proven by
determining the expression of chlamydial genes pyk (open bars, p=0.03) and rpoA (closed bars, p=0.01) mRNA (F; n=3).
doi:10.1371/journal.pone.0006020.g001
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MF are recruited by C. pneumoniae- infected PMN. A screening of
chemotactic proteins revealed that C. pneumoniae- infection of PMN
resulted in an increased production of MIP-1ß as compared to
mock- stimulated PMN (Fig. 3A). Using an in vitro chemotaxis
assay we found, that supernatants taken from C. pneumoniae-
infected PMN attracted monocytes significantly better when
compared to supernatants taken from mock- stimulated PMN
(Fig. 3B, p=0.04; n=3). Having shown that PS- positive apoptotic
PMN harbor viable chlamydiae and subsequently recruit mono-
cytes, we wondered whether these cells are ingested by monocyte-
derived macrophages. In a co- culture of PS- positive C. pneumoniae-
infected PMN with MF, PMN were rapidly engulfed by MF
(15 min) and could be observed within the MF phagosome by
electron microscopy (Fig. 3C).
PMN passage increases transmission of C. pneumoniae to
macrophages
To follow the intracellular fate of C. pneumoniae in monocyte-
derived macrophages (MF) and alveolar macrophages (AM) we
used intracellular C. pneumoniae LPS- staining and FACS
analysis. Whereas only 21%65% (n=3) of MF stained C.
pneumoniae LPS- positive after direct C. pneumoniae infection (18 h
p.i.), co- incubation of MF with C. pneumoniae-i n f e c t e da p o p t o t i c
PMN resulted in significantly higher amount of C. pneumoniae
LPS- positive MF (65%66%, p=0.004; n=3) (Fig. 4A). The
higher efficacy in C. pneumoniae- infection of MF via apoptotic
PMN was still observed 90 h p.i., showing more than 5-fold
more C. pneumoniae LPS- positive cells compared to the direct
infection of MF (75%65% vs. 14%68 % ,p = 0 . 0 0 4 ;n = 3 ) .
Increased bacterial load in MF that were infected through
apoptotic PMN corresponded to larger intracellular C.
pneumoniae inclusions (Fig. 4B) in comparison to directly infected
MF (Fig. 4C).
To bring the PMN passage strategy closer to respiratory C.
pneumoniae infection, we repeated the experiments using purified
alveolar macrophages (AM) from bronchoalveolar lavage (BAL)
f l u i d .T oa n a l y z ed i f f e r e n c ei nt h ei n f e c t i o np a t t e r no fA Mt h a t
were directly infected with C. pneumoniae vs. AM that were co-
incubated with C. pneumoniae- infected apoptotic PMN we
calculated the amount of small and large inclusions inside these
cells (Fig. 5A–C). Thus, large inclusions were almost exclusively
observed in AM that were infected by PS- positive C. pneumoniae-
infected PMN (6%61.8% vs. 0.560.5%, p=0.02; n=3),
whereas the appearance of small inclusions did not differ
between both conditions (Fig. 5A). The same pattern of
intracellular chlamydial inclusions was observed in AM isolated
from C. pneumoniae- DNA positive BAL fluids of patients with
community-acquired pneumonia, but not in C. pneumoniae-D N A
negative samples (Fig. 5D,E).
Transmission of C. pneumoniae infection from PMN to
macrophages depend on PS
To investigate the mechanisms of C. pneumoniae transfer from
apoptotic PMN to MF we tried to inhibit the uptake of apoptotic
cells by blocking the apoptotic eat me signal PS on infected PMN.
We compared MF that were co- incubated with C. pneumoniae-
infected apoptotic PMN with MF that were co- incubated with C.
pneumoniae- infected apoptotic PMN after preincubation with PS-
binding AnxA5. Both types of MF stained positive for C.
pneumoniae-LPS (Fig. 6A,B). However, the C. pneumoniae staining
pattern in MF that were infected in the presence of PS- masking
AnxA5 revealed less and smaller inclusions (Fig. 6B) similar to the
staining we observed after direct infection of macrophages (Fig. 4C
Figure 2. C. pneumoniae hides inside PS- positive PMN. To analyze early and late apoptotic markers, PMN were infected with C. pneumoniae or
left in medium alone. Using Anxa5-fluos and propidium iodide (PI) staining we could show that both non- infected (.95%, A) and C. pneumoniae-
infected (82%612%, B) PMN become PS- positive within 66 h without significant changes in the amount of PI- positive necrotic cells (representative
experiment out of 3). To visualize whether C. pneumoniae- infected PMN stain positive for PS we performed a double staining using a FITC- labeled
anti-C. pneumoniae LPS mAb and Alexa568-labeled AnxA5 (C). In contrast, late apoptotic cells as determined by TUNEL staining (closed line) were
more often found in the medium control than in C. pneumoniae- infected PMN (D, E; representative experiment out of 3).
doi:10.1371/journal.pone.0006020.g002
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number of large inclusions in MF, indicative for reduced bacterial
load and replicative activity (Fig. 6C, p=0.02). Using an AnxA5-
based MACS separation system we were able to separate PS-
positive C. pneumoniae- infected PMN from PS- negative cells,
showing that only co- incubation with PS- positive PMN resulted
in transfer of C. pneumoniae infection to MF (data not shown).
Furthermore, expression of the chlamydial 16S rRNA in MF was
decreased more than 2-fold when the PMN uptake was blocked by
AnxA5 (Fig. 6D, n=3). Reduced bacterial load in MF pre-
incubated with AnxA5 was accompanied by reduced transcrip-
tional activity of the rpo and pyk gene indicative for impaired
growth and progeny of chlamydiae (Fig. 6E, n=3).
PS- dependent uptake of C. pneumoniae infected PMN
silences MF immune response
We wondered whether the uptake of apoptotic C. pneumoniae-
infected PMN would induce activation or silencing of MF, and
therefore analyzed the expression of the pro- inflammatory and
anti- inflammatory cytokines TNF-a and TGF-ß. We observed a
significant reduction of TNF-a release from MF after uptake of C.
pneumoniae- infected apoptotic PMN as compared to direct
infection with C. pneumoniae (Fig. 7A, p=0.01). In contrast, PMN
that were not- infected by C. pneumoniae became secondarily
necrotic after 3 days, and the uptake of these late apoptotic PMN
resulted in enhanced TNF-a release when compared to non-
stimulated macrophages alone (data not shown). In contrast, the
uptake of C. pneumoniae- infected apoptotic PMN significantly
increased the production of TGF-ß as compared to direct infection
with C. pneumoniae (Fig. 7B, p=0.02). Blocking PS on apoptotic
PMN by AnxA5 pre- incubation reduced the production of TGF-ß
but without reaching statistical significance (n=3).
Discussion
The life span of infectious C. pneumoniae elementary bodies (EB)
is limited outside a human host cell. The pathogen strongly
depends on the host cell environment for progeny and systemic
dissemination. Alveolar macrophages (AM) are the pre-dominant
cells in the human lung and represent the first line of defense in
respiratory infections. Upon bacterial challenge the amount of
PMN increases dramatically in the lung, accounting for more than
80% of the cells in acute respiratory tract infections. Whereas
direct infection of macrophages results in clearance of the
pathogen, uptake of C. pneumoniae by PMN has been shown to
promote intracellular survival [4]. Nevertheless, although C.
pneumoniae is frequently found inside PMN in early respiratory
infections, the infection of macrophages seems crucial for systemic
dissemination of the pathogen [1,18]. C. pneumoniae survive and
replicate inside PMN as shown by the transcriptional activity data
and increased LPS expression, however, we did not succeed to
transmit chlamydial infection from PMN to epithelial cells, which
are primarily used for culture of chlamydiae. We found that in the
presence of PMN lysates, containing high amounts of degrading
enzymes from disrupted granules, chlamydial growth was
precluded, even when epithelial cells were directly infected with
C. pneumoniae (data not shown). Importantly, there is good evidence
from in vivo data that the influx of PMN in acute lung infection
with C. pneumoniae favors chlamydial growth and results in
increased bacterial load in mice [19]. In contrast, lack of PMN
recruitment in MyD88-deficient mice resulted in lower bacterial
load of infected lungs, although the underlying mechanisms for
enhanced chlamydial progeny and dissemination in the presence
of PMN remained to be explained [19]. Gueinzius et al. could
previously show, that PMN might serve as a vector for systemic C.
pneumoniae dissemination as the infection can be transmitted to
vascular endothelial cells [20]. However, mechanisms of cell to cell
transfer of obligate intracellular bacteria are largely unknown, but
it has been speculated that chlamydiae might profit from hiding
inside apoptotic cells [15]. First evidence supporting this
hypothesis came up recently as it has been demonstrated that C.
pneumoniae can be transferred from UV-killed, PS-positive mouse
embryonic fibroblasts to mouse DCs [21].
Blood monocytes and monocyte- derived macrophages are
supposed to be the vector for systemic dissemination of C.
pneumoniae throughout the human body. In up to 25% of healthy
blood donors C. pneumoniae can be detected in circulating
monocytes by PCR or culture [22]. Blood monocytes have been
Figure 3. Increased MIP-1ß release in C. pneumoniae infected
PMN. PMN were infected with C. pneumoniae (closed circles) or mock
infected with HEp-2 lysates (open circles) (A). Increased secretion of
MIP-1ß was observed in the supernatants of C. pneumoniae- infected
PMN at the given time points by ELISA (A). The chemotactic index
(specific migration/migration towards medium) indicates that mono-
cytes are significantly better attracted by supernatants taken from C.
pneumoniae- infected PMN than mock- infected control cells (B,
p=0.04; n=3). Using transmission electron microscopy we could show
that C. pneumoniae- infected PMN are engulfed by monocyte- derived
macrophages (C). Arrows indicate the phagosomal membrane (PM) of
the macrophage; containing a complete apoptotic PMN with con-
densed nucleus (N) (bar equals 1 mm, magnification 60006).
doi:10.1371/journal.pone.0006020.g003
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PMN (closed bars, 66 h p.i.) were co incubated with autologous macrophages (MF) at ratio of 1:1 (A–C). The amount of C. pneumoniae- positive (C.
pneumoniae LPS- staining) MF increased significantly after 18 and 90 h when MF were co incubated with C. pneumoniae- infected apoptotic PMN (A,
p=0.004), but not upon direct C. pneumoniae infection. Fluorescence microscopy revealed that co incubation of MF with C. pneumoniae- infected
apoptotic PMN for 90 h resulted in multiple large inclusions (B) whereas directly infected MF showed smaller ‘‘persistent-like’’ inclusions (C;
magnification 6306).
doi:10.1371/journal.pone.0006020.g004
Figure 5. Alveolar macrophages harbor intracellular chlamydiae in vivo. Alveolar macrophages (AM) isolated from BAL fluids of C.
pneumoniae- DNA negative patients were either directly infected with C. pneumoniae (open bars) or co incubated with C. pneumoniae infected PMN
at a ratio of 1:1 (closed bars, 66 h p.i.). The percentage of AM harvesting large and small inclusions were calculated 90 h p.i. by counting a minimum
of 200 cells/slide using a FITC- labeled anti- C. pneumoniae LPS- staining protocol (A). Significantly more large chlamydial inclusions were detected in
AM co incubated with C. pneumoniae- infected apoptotic PMN than in directly infected AM (A–C, p=0.02). In addition, we analyzed AM from BAL
fluids of patients suffering from community-acquired pneumonia (CAP) by fluorescence microscopy (D, E; representative experiment out of 4),
showing both small, persistent-like inclusions (downward arrows) and large inclusions (upward arrows) in C. pneumoniae- DNA positive BAL (D) but
not in C. pneumoniae- DNA negative BAL (E).
doi:10.1371/journal.pone.0006020.g005
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transmission of the infection to endothelial or smooth muscle cells
in vitro [24,25]. Of clinical importance is the fact, that most of the
chlamydiae enter a persistent-like state in monocytes that is
refractory to current antibiotic treatment strategies [26,27]. When
compared to the infection of epithelial cells, growth of C.
pneumoniae is strongly restricted in monocytes and monocyte-
derived macrophages upon direct infection [24,28].
The data presented here underline the importance for C.
pneumoniae to be taken up by PMN to increase viability and
virulence in macrophages. Sheltered by the ‘‘PMN envelope’’ and
recognized by an apoptotic ‘‘eat-me signal’’ C. pneumoniae is
ingested by MF and AM without being visible for the innate
immune system.
The physiological clearance of tissue granulocytes is normally
silent, but can under certain situations shift to become a pro-
inflammatory event. For example, apoptotic cells that escape
phagocytosis, disintegrate in a pro-inflammatory process called
secondary necrosis. Importantly, uptake of non- infected late
apoptotic PMN by MF did not result in ‘‘silencing’’ of the
macrophage immune response. This is in line with findings from
Afonso et al. showing decreased intracellular survival of
Leishmania amazonensis when late apoptotic PMN were
uptaken [29]. Recent studies demonstrated that also viruses
and parasites misuse the apoptotic ‘‘eat-me signal’’ PS for
productive infection [30,31]. In general, phosphatidylserine (PS)
on the outer membrane of apoptotic cells is the key element for
induction of an anti-inflammatory environment. Therefore the
mere presence of apoptotic cells at the site of infection is
beneficial during the transfer of obligate intracellular pathogens
from one to the next host cell. Blocking experiments with AnxA5
revealed that PS expression on apoptotic C. pneumoniae infected
PMN is important for the productive transfer of not only C.
pneumoniae but also C. trachomatis L2 (Fig. S1) from PMN into
macrophages.
Regarding acute C. pneumoniae infections of the lower respiratory
tract in humans, it seems to be a footrace between direct clearance
of C. pneumoniae by AM and ingestion of C. pneumoniae by PMN
which might increase chlamydial pathogenicity. Whether direct
clearance of C. pneumoniae by MF results in complete eradication of
the pathogen or promotes persistence of chlamydiae in the lung
still has to be determined. Morphological analysis of C. pneumoniae
inclusions in AM from C. pneumoniae- DNA positive BAL fluids
suggests that direct and indirect ingestion of chlamydiae may
occur in vivo.
These data show that C. pneumoniae infection of MF results in
increased pathogen activity and silenced immune response when
transferred by apoptotic PMN. However in acute infection, the
innate and acquired immune mechanisms will be turned on by
direct host-pathogen interactions in order to limit infection to the
lungs. Thus, pro- inflammatory immune responses will be
generated by direct contact of chlamydial TLR- ligands with its
specific receptors [19,32] and MHC class I-restricted lysis of
infected cells by CD8(+) CTL will occur to prevent systemic
dissemination of the pathogen [33].
We demonstrated that C. pneumoniae remain transcriptionally
active inside PMN and induce the release of macrophage
attracting MIP-1ß. C. pneumoniae hiding inside apoptotic PMN
were phagocytosed by MF and developed multiple large inclusions
inside MF. In contrast, direct C. pneumoniae infection of MF
resulted in a persistent-like infection. Efficient uptake and
intracellular development of C. pneumoniae in MF via apoptotic
PMN was dependent on the expression of phosphatidylserine on
infected cells. Our data suggest that C. pneumoniae misuses central
pathways of apoptotic cell clearance to survive inside human cells.
Further studies are needed to elucidate the functional role of this
Figure 6. PS- dependent transmission of C. pneumoniae infection. Blocking of phosphatidylserine (PS) expression on C. pneumoniae- infected
PMN by preincubation with recombinant AnxA5 significantly reduced the uptake of chlamydiae (A, B) and the formation of large inclusions (C,
p=0.02; n=3) as shown by fluorescence microscopy with FITC- labeled anti- C. pneumoniae LPS- staining (representative experiment out of 3,
magnification 6306) and calculation of a minimum of 200 cells/slide (C). Replicative activity of C. pneumoniae, indicated by the amount of 16S rRNA
(D), pyk (open bars) and rpo (closed bars) mRNA expression compared to host cell 18S rRNA expression (E), decreased in MF when C. pneumoniae-
infected PMN were preincubated with AnxA5 (representative experiment out of 3).
doi:10.1371/journal.pone.0006020.g006
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the circulation in humans after acute respiratory infection.
Materials and Methods
Bacterial strain, cell preparation and infection
experiments
The C. pneumoniae strain CV-6, used in this study, was isolated
from a coronary artery plaque and continuously propagated on
HEp-2 cells as described [34].
PMN and monocyte- derived macrophages (MF) were gener-
ated from buffy coat blood as described previously [4,35]. Alveolar
macrophages (AM) were isolated from bronchoalveolar lavage
(BAL) fluid [8] from healthy volunteers (C. pneumoniae- DNA
negative) and patients with acute C. pneumoniae infection as proven
by C. pneumoniae- DNA positive PCR results from BAL (n=4).
Cells were cultured for 1 to 4 days at 37uC in a humidified
atmosphere (5% CO2) in RPMI 1640 medium, containing 50 mM
2-mercaptoethanol, 2 mM L-glutamine, 10 mM HEPES comple-
mented with 10% FCS (all Sigma-Aldrich, Munich, Germany).
PMN (1610
7/ml) were co- incubated with C. pneumoniae at a
ratio of 1:1 (MOI 1), equivalent amounts of heat-killed C.
pneumoniae, or with mock infected HEp-2 cell lysates as negative
controls. 3 hours after co incubation PMN were separated from
extracellular C. pneumoniae by several washing and centrifugation
steps at 2006g. MF or AM were co- incubated with C. pneumoniae-
infected PMN (66 h p.i.) at a PMN to macrophage ratio of 1:1, or
directly infected with C. pneumoniae with a MOI 1. Blocking
experiments for phosphatidylserine specific uptake of C. pneumo-
niae- infected PMN were performed with recombinant Annexin A5
(AnxA5; Responsif GmbH, Erlangen Germany) at a concentration
of 5 mg/1610
6 PMN.
Immunohistochemistry, Western blot analysis and
electron microscopy of infected cells
For C. pneumoniae- specific staining the cells were cytocentri-
fuged, fixed in methanol and stained using a FITC-conjugated
anti-C. pneumoniae mAb (clone RR402, IgG3, Dako, Hamburg,
Germany) or a FITC-conjugated isotype matched control mAb
(Dako), followed by counterstaining with Evans blue. Inclusion
morphology was analyzed under a Zeiss Axioskop-2H fluorescent
microscope fitted with HRS- AxiocamH and Axiovision software
4.5H. Percentages of C. pneumoniae- LPS positivity was calculated by
counting a minimum of 200 cells/slide. For structure preservation
electron microscopy, MF were co- incubated for 15 min with C.
pneumoniae - infected PMN at a ratio of 1:1. Cells were fixed and
examined with a Philips EM 400 electron microscope as described
[35].
Flow cytometry analysis
Intracellular C. pneumoniae LPS was quantified using FACS
analysis. Cells were permeabilized using the Cytofix/Cytoperm
Plus Kit (BD Biosciences, Heidelberg, Germany) as recommended
by the manufacturer and stained with a FITC-conjugated anti- C.
pneumoniae mAb or an isotype matched control (both Dako).
Annexin A5 (AnxA5), propidium iodide and TUNEL staining
were performed as described [4]. In addition we stained cells with
Alexa568-conjugated AnxA5 followed by an intracellular C.
pneumoniae LPS staining as described above. To maintain AnxA5
binding to PS the intracellular C. pneumoniae staining was
performed in the presence of 5 mM CaCl2.
Real-Time PCR
Total RNA isolation, generation of cDNA and PCR amplifi-
cation was performed as described [36]. The expression of the
chlamydial 16S rRNA (forward [TCG CCT GGG AAT AAG
AGA GA]; reverse [AAT GCT GAC TTG GGG TTG AG]),
rpoA (forward [GCAATCGAAGGGGTTATTGA]; reverse
[TGATCTGGGTTAACG GCTTC]), pyk (forward [AGC
TTG CGG ATG GAA TTA TG]; reverse [ATG CAG TTT
CCC CTG ACA AC]), and 18S rRNA (forward [TCA AGA
ACG AAA GTC GGA GG], reverse [GGA CAT CTA AGG
GCA TCA CA]) was analyzed by relative quantification using the
DDct- method as shown before [36]. Changes in the mRNA
expression profile over time were calculated by comparing values
for 66 h p.i. to values for 3 h p.i. which were set to 1 for clear
presentation.
Cytokine measurement and chemotaxis assay
Cells were cultured and supernatants were collected after given
time points and stored at -20uC until cytokine determination.
MIP-1ß, TNF-a and TGF-ß was measured using ELISA (R&D
Systems, Wiesbaden, Germany) according to the manufacturer’s
instructions (duplicate assays for at least 3 independent experi-
ments). Chemotaxis assays were performed with freshly isolated
monocytes in 24-well Transwell plates (Costar, Bodenheim,
Germany) as described before [35]. The chemotactic index (CI)
was calculated by dividing the number of migrated cells towards
supernatants taken from C. pneumoniae- infected PMN, divided by
the number of cells migrated in medium alone.
Figure 7. Silencing of MF immune response to chlamydial
infection by PMN passage. Immune responses of directly C.
pneumoniae- infected MF were analyzed in comparison to MF either
co incubated with C. pneumoniae- infected PMN (66 h p.i.) or with C.
pneumoniae- infected PMN after precinubation with recombinant
AnxA5. Within 18 h p.i. supernatants of MF were collected to determine
total amounts of TNF-a (A) and TGF-ß (B) by ELISA. Direct infection of
MF with C. pneumoniae significantly increased TNF-a production (A,
p=0.01; n=3), whereas the uptake of C. pneumoniae-i n f e c t e d
apoptotic PMN was characterized by a significant up regulation of
TGF-ß in MF (B, p=0.02; n=3).
doi:10.1371/journal.pone.0006020.g007
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Data are depicted as mean6standard error of the mean.
Statistical significance of the results was analyzed with Student’s t
test and Microsoft Excel 8.0H software. Results were considered
statistically significant at p,0.05 (
*) and p,0.005 (
**).
Supporting Information
Figure S1 PS- dependent transmission of C. trachomatis infection.
Blocking of phosphatidylserine (PS) expression on C. trachomatis
(L2) infected PMN by preincubation with recombinant AnxA5
significantly reduced the uptake of chlamydiae (n=4, p=0.005).
Percentages of C. trachomatis - LPS positivity was calculated by
counting a minimum of 200 cells/slide stained with FITC- labeled
anti- chlamydial - LPS staining.
Found at: doi:10.1371/journal.pone.0006020.s001 (0.64 MB TIF)
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